Not true: insulin is not a drug whose price is being negotiated here (https://www.jmcp.org/doi/full/10.18553/jmcp.2023.29.3.229). The drugs whose prices are being negotiated are the brand new ones, the ones that took billions of dollars to develop. Without the promise of a payoff, future R&D will be halted, and humanity won't get benefit from the new medicines.
arp242|2 years ago
"If you don't pay us through the nose with billions we'll stop developing drugs" seems like a rather odd argument; disallowing the government from engaging in the free market on price in pretty much any area it would set of all sorts of corruption red flags. This is why all sorts of regulation around public procurements exist in almost any jurisdiction.
If you need money to develop new drugs: fine, this is why things like grants exist. Right now the drug companies want to have the best of all worlds with none of the obligations and downsides: inflated prices from Medicare are just tax subsidies but without any controls or checks or anything.
willio58|2 years ago
owisd|2 years ago
hackeraccount|2 years ago
My understanding (and I don't have the time to look this up) is that insulin is complicated. It's not a single thing - and variations are currently being developed.